BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

659 related articles for article (PubMed ID: 8567964)

  • 21. Binding interactions of leukemia inhibitory factor and ciliary neurotrophic factor with the different subunits of their high affinity receptors.
    Robledo O; Auguste P; Coupey L; Praloran V; Chevalier S; Pouplard A; Gascan H
    J Neurochem; 1996 Apr; 66(4):1391-9. PubMed ID: 8627290
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Formation of autocrine loops in human cerebral meningioma tissue by leukemia inhibitor factor, interleukin-6, and oncostatin M: inhibition of meningioma cell growth in vitro by recombinant oncostatin M.
    Schrell UM; Koch HU; Marschalek R; Schrauzer T; Anders M; Adams E; Fahlbusch R
    J Neurosurg; 1998 Mar; 88(3):541-8. PubMed ID: 9488310
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Definition of receptor binding sites on human interleukin-11 by molecular modeling-guided mutagenesis.
    Tacken I; Dahmen H; Boisteau O; Minvielle S; Jacques Y; Grötzinger J; Küster A; Horsten U; Blanc C; Montero-Julian FA; Heinrich PC; Müller-Newen G
    Eur J Biochem; 1999 Oct; 265(2):645-55. PubMed ID: 10504396
    [TBL] [Abstract][Full Text] [Related]  

  • 24. GP130/OSMR is the only LIF/IL-6 family receptor complex to promote osteoblast differentiation of calvaria progenitors.
    Malaval L; Liu F; Vernallis AB; Aubin JE
    J Cell Physiol; 2005 Aug; 204(2):585-93. PubMed ID: 15751050
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A ciliary neurotrophic factor-sensitive human myeloma cell line.
    Gu ZJ; Zhang XG; Hallet MM; Lu ZY; Wijdenes J; Rossi JF; Klein B
    Exp Hematol; 1996 Aug; 24(10):1195-200. PubMed ID: 8765494
    [TBL] [Abstract][Full Text] [Related]  

  • 26. AIDS-associated Kaposi's sarcoma (KS) cells express oncostatin M (OM)-specific receptor but not leukemia inhibitory factor/OM receptor or interleukin-6 receptor. Complete block of OM-induced KS cell growth and OM binding by anti-gp130 antibodies.
    Murakami-Mori K; Taga T; Kishimoto T; Nakamura S
    J Clin Invest; 1995 Sep; 96(3):1319-27. PubMed ID: 7657807
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dual oncostatin M (OSM) receptors. Cloning and characterization of an alternative signaling subunit conferring OSM-specific receptor activation.
    Mosley B; De Imus C; Friend D; Boiani N; Thoma B; Park LS; Cosman D
    J Biol Chem; 1996 Dec; 271(51):32635-43. PubMed ID: 8999038
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Signaling of type II oncostatin M receptor.
    Auguste P; Guillet C; Fourcin M; Olivier C; Veziers J; Pouplard-Barthelaix A; Gascan H
    J Biol Chem; 1997 Jun; 272(25):15760-4. PubMed ID: 9188471
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Proliferative responses and binding properties of hematopoietic cells transfected with low-affinity receptors for leukemia inhibitory factor, oncostatin M, and ciliary neurotrophic factor.
    Gearing DP; Ziegler SF; Comeau MR; Friend D; Thoma B; Cosman D; Park L; Mosley B
    Proc Natl Acad Sci U S A; 1994 Feb; 91(3):1119-23. PubMed ID: 8302840
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Different epitopes are required for gp130 activation by interleukin-6, oncostatin M and leukemia inhibitory factor.
    Timmermann A; Pflanz S; Grötzinger J; Küster A; Kurth I; Pitard V; Heinrich PC; Müller-Newen G
    FEBS Lett; 2000 Feb; 468(2-3):120-4. PubMed ID: 10692570
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of mRNAs for ciliary neurotrophic factor (CNTF), leukemia inhibitory factor (LIF), interleukin-6 (IL-6), and their receptors (CNTFR alpha, LIFR beta, IL-6R alpha, and gp130) in human peripheral neuropathies.
    Ito Y; Yamamoto M; Mitsuma N; Li M; Hattori N; Sobue G
    Neurochem Res; 2001 Jan; 26(1):51-8. PubMed ID: 11358282
    [TBL] [Abstract][Full Text] [Related]  

  • 32. LIFR beta and gp130 as heterodimerizing signal transducers of the tripartite CNTF receptor.
    Davis S; Aldrich TH; Stahl N; Pan L; Taga T; Kishimoto T; Ip NY; Yancopoulos GD
    Science; 1993 Jun; 260(5115):1805-8. PubMed ID: 8390097
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of ciliary neurotrophic factor (CNTF) residues essential for leukemia inhibitory factor receptor binding and generation of CNTF receptor antagonists.
    Di Marco A; Gloaguen I; Graziani R; Paonessa G; Saggio I; Hudson KR; Laufer R
    Proc Natl Acad Sci U S A; 1996 Aug; 93(17):9247-52. PubMed ID: 8799186
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The IL-6 family cytokines, interleukin-6, interleukin-11, oncostatin M, and leukemia inhibitory factor, enhance mast cell growth through fibroblast-dependent pathway in mice.
    Gyotoku E; Morita E; Kameyoshi Y; Hiragun T; Yamamoto S; Hide M
    Arch Dermatol Res; 2001 Nov; 293(10):508-14. PubMed ID: 11820727
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A sweat gland-derived differentiation activity acts through known cytokine signaling pathways.
    Habecker BA; Symes AJ; Stahl N; Francis NJ; Economides A; Fink JS; Yancopoulos GD; Landis SC
    J Biol Chem; 1997 Nov; 272(48):30421-8. PubMed ID: 9374533
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interleukin-6-type cytokines stimulate mesenchymal progenitor differentiation toward the osteoblastic lineage.
    Taguchi Y; Yamamoto M; Yamate T; Lin SC; Mocharla H; DeTogni P; Nakayama N; Boyce BF; Abe E; Manolagas SC
    Proc Assoc Am Physicians; 1998; 110(6):559-74. PubMed ID: 9824538
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ciliary neurotropic factor, interleukin 11, leukemia inhibitory factor, and oncostatin M are growth factors for human myeloma cell lines using the interleukin 6 signal transducer gp130.
    Zhang XG; Gu JJ; Lu ZY; Yasukawa K; Yancopoulos GD; Turner K; Shoyab M; Taga T; Kishimoto T; Bataille R
    J Exp Med; 1994 Apr; 179(4):1337-42. PubMed ID: 8145045
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential response of neuronal cells to a fusion protein of ciliary neurotrophic factor/soluble CNTF-receptor and leukemia inhibitory factor.
    März P; Ozbek S; Fischer M; Voltz N; Otten U; Rose-John S
    Eur J Biochem; 2002 Jun; 269(12):3023-31. PubMed ID: 12071967
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Soluble glycoprotein 130 (gp130) attenuates OSM- and LIF-induced cartilage proteoglycan catabolism.
    Hui W; Bell M; Carroll G
    Cytokine; 2000 Feb; 12(2):151-5. PubMed ID: 10671300
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential inhibition of IL-6-type cytokine-induced STAT activation by PMA.
    Terstegen L; Maassen BG; Radtke S; Behrmann I; Schaper F; Heinrich PC; Graeve L; Gatsios P
    FEBS Lett; 2000 Jul; 478(1-2):100-4. PubMed ID: 10922477
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.